Atlas FDA

SFS

1 FDA 510(k) clearances · Product code

FDA profile

Official device name
Revumenib Eligibility Detection System
Device class
Class II (moderate risk)
Regulation
21 CFR 864.1885
Medical specialty
Hematology
FDA definition
A revumenib eligibility detection system is identified as a prescription in vitro diagnostic device intended for the qualitative detection of structural abnormalities of chromosome 11 in specimens from patients with acute leukemia for the purpose of identifying patients who may benefit from treatment with revumenib, in accordance with the approved therapeutic product labeling.
Sort:Newest firstOldest first

Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free

RecordFirmDate
KMT2A Breakapart FISH Probe Kit PDx (CDA-LPH013) (DEN240067)Cytocell Limited2025-09-19

Track SFS automatically

Every clearance here is in the API, with alerts when new ones post.